Brief: Neubase Therapeutics Appoints William Mann As Chief Operating Officer
28/07/2020 13:06
July 28 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS STRENGTHENS SENIOR MANAGEMENT TEAM
WITH
APPOINTMENT OF INDUSTRY VETERAN WILLIAM MANN, PH.D., MBA AS
CHIEF OPERATING OFFICER
Source text for Eikon: ID:nGNX3V5mqT
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet